Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Human adenovirus infections
MeSH D000258 - human adenovirus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000257:
Adenoviridae infections
0 Companies
0 Drugs
Success rate
D000258:
Human adenovirus infections
12 Companies
3 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Ribavirin
Roche
Peginterferon alfa-2a
,
Ribavirin
Sandoz
Ribavirin
Bausch Health Companies
Ribavirin
Merck & Co
Peginterferon alfa-2b
,
Ribavirin
Aurobindo Pharma
Ribavirin
Zydus Therapeutics
Ribavirin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use